Better Money Decisions, LLC Abb Vie Inc. Transaction History

Better Money Decisions, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $1,156 - $1,332	-8 Reduced 0.46%	1,727 $275,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $239,967 - $287,784	1,735 New	1,735 $280,000
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $8,945 - $11,372	65 New	65 $10,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $15,577 - $19,709	-145 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $106 - $120	1 Added 0.69%	145 $16,000
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $5,365 - $5,977	51 Added 54.84%	144 $16,000
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $9,513 - $10,473	93 New	93 $10,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Better Money Decisions, LLC, based on Form 13F filings with the SEC.

Stay updated on Better Money Decisions, LLC with notifications on news.